HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhuang Chen Selected Research

ginsenoside Rb3

8/2022Ginsenoside Rb3 attenuates skin flap ischemia-reperfusion damage by inhibiting STING-IRF3 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhuang Chen Research Topics

Disease

15Neoplasms (Cancer)
06/2022 - 02/2002
3Diarrhea
03/2018 - 01/2017
2Neoplasm Metastasis (Metastasis)
01/2021 - 04/2005
2Sepsis (Septicemia)
11/2020 - 05/2019
2Necrosis
04/2005 - 02/2003
1Reperfusion Injury
08/2022
1Bites and Stings (Sting)
08/2022
1Ischemia
08/2022
1Embolism (Embolus)
07/2022
1Edema (Dropsy)
07/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Severe Acute Respiratory Syndrome
01/2021
1Shellfish Poisoning
07/2020
1Hypoxia (Hypoxemia)
05/2019
1Cardiomyopathies (Cardiomyopathy)
05/2019
1Heart Failure
05/2019
1Septic Shock (Toxic Shock Syndrome)
09/2016
1Inflammation (Inflammations)
06/2016
1Lymphoma (Lymphomas)
04/2016
1Osteoporosis
12/2015
1Bone Resorption
12/2015
1Bone Diseases (Bone Disease)
12/2015
1Myocardial Infarction
11/2012
1Cardiac Sudden Death (Sudden Cardiac Arrest)
12/2011
1Cardiomegaly (Heart Hypertrophy)
12/2011
1Aneurysm (Aneurysms)
06/2008
1Infections
12/2006

Drug/Important Bio-Agent (IBA)

3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2006 - 09/2002
3AntigensIBA
04/2005 - 09/2002
3VaccinesIBA
04/2005 - 02/2002
2Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2016
2Pharmaceutical PreparationsIBA
01/2021 - 05/2019
2Biological ProductsIBA
01/2021 - 01/2021
2CytokinesIBA
06/2016 - 09/2002
2Neoplasm Antigens (Tumor Antigens)IBA
04/2005 - 09/2002
21-palmitoyl-lysophosphatidic acid (PLPA)IBA
08/2003 - 02/2002
2Peptides (Polypeptides)IBA
11/2002 - 02/2002
1ginsenoside Rb3IBA
08/2022
1P-SelectinIBA
08/2022
1Circular RNAIBA
06/2022
1Long Noncoding RNAIBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Biocompatible Materials (Biomaterials)IBA
01/2021
1Metal-Organic FrameworksIBA
01/2021
1B7-H1 AntigenIBA
01/2021
1Hemoglobins (Hemoglobin)IBA
11/2020
1PotassiumIBA
11/2020
1NitrogenIBA
11/2020
1Urea (Carbamide)FDA LinkGeneric
11/2020
1Coloring Agents (Dyes)IBA
07/2020
1AcidsIBA
01/2020
1GoldIBA
01/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2019
1Simendan (Levosimendan)IBA
05/2019
1PutrescineIBA
03/2018
1Histamine (Histamine Dihydrochloride)FDA Link
03/2018
1AmmoniaIBA
03/2018
1AntioxidantsIBA
02/2017
1Anti-Bacterial Agents (Antibiotics)IBA
02/2017
1Zinc OxideFDA Link
01/2017
1LipopolysaccharidesIBA
09/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2016
1Mitogen-Activated Protein KinasesIBA
04/2016
1Messenger RNA (mRNA)IBA
04/2016
1deoxypyridinolineIBA
12/2015
1CreatinineIBA
11/2012
1Trinitrotoluene (TNT)IBA
11/2012
1Biomarkers (Surrogate Marker)IBA
11/2012
1Troponin IIBA
11/2012
1Troponin T (Troponin T1)IBA
11/2012
1MicroRNAs (MicroRNA)IBA
11/2012
1CalciumIBA
12/2011
1InterleukinsIBA
12/2006
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2006
1TitaniumIBA
08/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2005
1DNA (Deoxyribonucleic Acid)IBA
11/2002
1ElementsIBA
11/2002
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
09/2002
1Cancer VaccinesIBA
02/2002
1Interleukin-12 (IL 12)IBA
02/2002
1CD40 Ligand (CD40L)IBA
02/2002

Therapy/Procedure

4Therapeutics
01/2022 - 04/2005
1Embolectomy
07/2022
1Stents
07/2022
1Immunotherapy
01/2022
1Perforator Flap
07/2021
1Precision Medicine
01/2021
1Photothermal Therapy
01/2020
1Electroacupuncture
12/2015
1Surgical Instruments (Clip)
06/2008
1Laminectomy
08/2006
1Radiotherapy
04/2005